PZ CORMAY SA Management Board based in Łomiankach ("Company"), with reference to Current Report No. 26/2018, informs that based on the Orphee SA subsidiary with its registered office in Geneva ("Orphee") a letter of intent with the entity interested in purchasing the entire package held Orphee shares in Diesse Diagnostica Senese SpA based in Milan (respectively "Entity Interested" and "Diesse") and as a result of the currently conducted Diesse (due diligence) examination, the Entity of Interest confirmed the intention of concluding the transaction.
Following an annex to the letter of intent regarding the sale of Diesse shares clarifying the preliminary conditions of the potential transaction was added, and the exclusivity period for negotiating the acquisition of shares in Diesse was extended until February 28, 2019, as part of which decisions will be made to conclude or failure to conclude a share sale transaction and transaction documents will be prepared.
Signing the above The annex is the next stage of the process, as a result of which, in the event of its successful completion, the shares in Diesse held by Orphee may be sold, however, continuing the process of preparing the transaction does not guarantee its completion.
Source: company website, investor relations, current and periodic reports.